Products

What will AGI do for Arformoterol?

This classification denotes a beta-adrenergic agonist with the molecular formula C19H24N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, F91H02EBWT chemically known as formamide, n-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)-, (2r,3r)-2,3-dihydroxybutanedioate (1:1) but generally known as arformoterol, which bears US NIH Compound Identifier 3083544. European Medicines Agency schedules Arformoterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB35021. The term ARFORMOTEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 18, no. 3, 2004, list 52). Most nations schedule arformoterol under HS 29242995 and SITC 51479. As of Q4 2014, ARFORMOTEROL remains the US FDA Preferred Term for this commodity. Arformoterol bears US NLM identifiers UMLS ID C0969589 and NCI Concept Code C61641. SMILES: CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O.